BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6177604)

  • 1. [Round table on the use of chromogenic substrates in hemostasiologic diagnosis].
    Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):189-200. PubMed ID: 6177604
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
    Bokarev IN; Butorov VN; Loginov LE
    Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood clotting diagnosis with chromogenic substrates].
    Róka L; Rasche H
    Internist (Berl); 1980 Apr; 21(4):189-94. PubMed ID: 6998907
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance of the amidolytic method in the typing of congenital antithrombin III deficiency].
    Losonczy H; Nagy I
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):184-8. PubMed ID: 6177603
    [No Abstract]   [Full Text] [Related]  

  • 5. Adaptation of synthetic peptide substrate-based assays on a discrete analyzer.
    Aiach M; Léon M; Michaud A; Capron L
    Semin Thromb Hemost; 1983 Jul; 9(3):206-16. PubMed ID: 6351255
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative studies on the determination of abnormal antithrombin III activity].
    Nagy I; Losonczy H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):180-3. PubMed ID: 6177602
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antithrombin III and its role in clinical pathology].
    Andreenko GV; Poliantseva LR; Podorol'skaia LV
    Ter Arkh; 1980; 52(2):141-5. PubMed ID: 6445606
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blood coagulation-fibrinolysis tests by a biochemical method].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1993 Jul; 41(7):743-9. PubMed ID: 8361043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition.
    Demers C; Henderson P; Blajchman MA; Wells MJ; Mitchell L; Johnston M; Ofosu FA; Fernandez-Rachubinski F; Andrew M; Hirsh J
    Thromb Haemost; 1993 Mar; 69(3):231-5. PubMed ID: 8470046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory evaluation of antithrombin III: a critical overview of currently available methods for antithrombin III measurements.
    Fareed J; Messmore HL; Walenga JM; Bermes EW; Bick RL
    Semin Thromb Hemost; 1982 Oct; 8(4):288-301. PubMed ID: 6817417
    [No Abstract]   [Full Text] [Related]  

  • 11. [Automation of colorimetry using chromogenic substrates, with special reference to blood coagulation disorders in acute myelocytic leukemia].
    Hashizume K; Tanaki T; Horita H; Yoshitani H; Kumatani Y; Matsuda T; Ito K
    Rinsho Byori; 1985 Feb; Spec No 61():114-8. PubMed ID: 3858561
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthetic peptide substrate assays in coagulation and fibrinolysis and their application on automates.
    Friberger P
    Semin Thromb Hemost; 1983 Oct; 9(4):281-300. PubMed ID: 6362011
    [No Abstract]   [Full Text] [Related]  

  • 13. [Respiratory failure and coagulation-fibrinolytic disorders].
    Nagata H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Feb; 25(2):188-94. PubMed ID: 3656809
    [No Abstract]   [Full Text] [Related]  

  • 14. Discrepancies between clotting and chromogenic assays in congenital coagulation disorders: the hemostatic coin has only one face, chromogenic substrates many.
    Girolami A; Vettore S
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):484-5. PubMed ID: 19675419
    [No Abstract]   [Full Text] [Related]  

  • 15. Chromogenic peptide substrate assays in patients with multiple trauma.
    Kierulf P; Aasen AO; Aune S; Godal HC; Ruud TE; Vaage J
    Acta Chir Scand Suppl; 1982; 509():69-72. PubMed ID: 6962622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antithrombin III determinations in internal medicine and surgery].
    Schmitz-Huebner U
    Med Lab (Stuttg); 1980 Sep; 33(9):232-5. PubMed ID: 7442606
    [No Abstract]   [Full Text] [Related]  

  • 17. Chromogenic methods in coagulation diagnostics.
    Rosén S
    Hamostaseologie; 2005 Aug; 25(3):259-66. PubMed ID: 16113749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antithrombin III (clinical aspects and methodology)].
    Abildgaard U
    Ric Clin Lab; 1978; 8 Suppl 2():90-7. PubMed ID: 106453
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antithrombin III activity in long-developing hypercoagulation in animals].
    Pastorova VE; Bazaz'ian GG; Liapina LA
    Biull Eksp Biol Med; 1984 Nov; 98(11):560-3. PubMed ID: 6509173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automation of antithrombin III methods on routinely available instruments.
    Conard J
    Semin Thromb Hemost; 1983 Oct; 9(4):263-7. PubMed ID: 6658460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.